Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Fanhdi 500 IU Injection
Fanhdi 500 IU Injection
Manufacturer/Marketed By : Grifols India Healthcare Private Limited
$108.74 $32.38
Fanhdi 500 IU Injection is a specialized treatment designed to manage and prevent bleeding episodes in individuals with hemophilia A, a genetic condition characterized by a deficiency in Factor VIII....
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Human Anti Haemophilic Factor Vill 500 IU
Active Pharmaceutical Ingredient
Fanhdi 500 IU Injection
108,74 US$
32,38 US$
Fanhdi 500 IU Injection is a specialized treatment designed to manage and prevent bleeding episodes in individuals with hemophilia A, a genetic condition characterized by a deficiency in Factor VIII. Derived from human plasma, this antihemophilic factor plays a crucial role in promoting blood clotting, making it essential for both routine care and surgical procedures in both adults and children. While effective for hemophilia A, it's important to note that Fanhdi is not suitable for treating von Willebrand disease, which involves a different clotting disorder. Patients receiving this injection should be aware of potential side effects, including allergic reactions, and should communicate any unusual symptoms to their healthcare provider immediately. Fanhdi helps enhance the quality of life for those living with hemophilia by significantly reducing the risk of bleeding complications. Always consult with a healthcare professional before starting treatment to ensure it aligns with your medical needs and history. For optimal results, follow the prescribed dosage and administration guidelines carefully.
Active Pharmaceutical Ingredient
Usos
• Fanhdi 500 iu injection is primarily used to prevent or control bleeding in patients diagnosed with Hemophilia A. This inherited disorder is characterized by a deficiency of clotting factor VIII, which is essential for normal blood coagulation. By administering Fanhdi 500 iu injection, healthcare providers can help manage bleeding episodes effectively. This treatment is crucial for maintaining the quality of life in individuals affected by this condition.
• In addition to managing spontaneous bleeding, Fanhdi 500 iu injection is also utilized during surgical procedures for individuals with Hemophilia A. The injection ensures that sufficient levels of factor VIII are present, thereby reducing the risk of excessive bleeding during and after surgery. This is particularly important for hemophilic patients who may face significant risks during invasive interventions. The use of Fanhdi 500 iu injection enables safer surgical outcomes.
• Fanhdi 500 iu injection plays a vital role in the long-term management of patients with Hemophilia A. Regular administration can help maintain adequate factor levels, which is essential for preventing future bleeding episodes. By incorporating Fanhdi 500 iu injection into their treatment regimen, patients can lead more active and fulfilling lives. This proactive approach helps minimize the complications associated with this bleeding disorder.
• For patients experiencing bleeding episodes, Fanhdi 500 iu injection serves as an effective treatment option. It acts quickly to replenish the missing clotting factor, allowing the body to respond appropriately to injury. This timely intervention is crucial in mitigating the severity of bleeding incidents. Fanhdi 500 iu injection is an integral part of the therapeutic arsenal for managing Hemophilia A.
Beneficios
Prevents or Controls Bleeding In Patients With Hemophilia A: The use of Fanhdi 500 IU Vial has proven to be effective in addressing the deficiency of circulating factor VIII in patients with haemophilia A, a sex-linked hereditary disorder of blood coagulation. This disorder causes a decrease in the level of factor VIII, resulting in excessive bleeding into joints, muscles, or internal organs. Whether it occurs spontaneously or due to accidental or surgical trauma, Fanhdi 500 IU Injection has demonstrated its ability to prevent or control such bleeding.
Efectos secundarios
As with all medicines, Fanhdi 500 IU Vial may have side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Efectos secundarios más comunes
• Chills
• Flushing
• Generalised urticaria
• Hives
• Hypotension
• Lethargy
• Restlessness
• Tachycardia
• Tightness of the chest
• Tingling
• Vomiting
• Wheezing
Efectos secundarios comunes
• Nervousness
• Headache
• Abdominal pain
• Nausea
• Paresthesia
• Blurred vision
• Angioedema
• Burning and stinging at the infusion site
Cómo utilizar
A doctor or nurse will give you Factor VIII Injection 500 IU in a hospital or clinic. It is important that you always follow your doctor's advice about the timing of your injection. The dose and frequency of administration will depend on the purpose of your treatment. You may also be given other medicines as part of your treatment. It is important that you take all of your medicine for the full prescribed time.
Consejos de seguridad
• Alcohol: Consumption of alcohol is not recommended while using Fanhdi 500 IU Injection. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you consumption of alcohol is safe or not.
• Kidney: No information is not avaliable for this medicine used in kidney disease patients. Please consult your doctor before using this Fanhdi Injection.
• Breastfeeding: Fanhdi 500 IU Injection should be given to breastfeeding mothers only if clinically indicated. The safety of this medicine used in breastfeeding mothers has not been established. It is not known whether this drug is excreted into human milk. Physicians should carefully consider the potential risks and benefits for each specific patient before prescribing Factor VIII Injection 500 IU.
• Liver: No information is not avaliable for this medicine used in liver disease patients. Please consult your doctor before using this Factor VIII Injection 500 IU.
• Pregnancy: Fanhdi 500 IU Injection should be given to a pregnant woman only if clearly needed. Animal reproduction studies have not been conducted with Fanhdi 500 IU. The safety of this medicine used in pregnant women has not been established. It is not known whether Fanhdi Injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
• Driving: Fanhdi Injection will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Fanhdi 500 IU such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.